🇺🇸 FDA
Patent

US 10596158

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

granted A61KA61K31/4418A61K31/444

Quick answer

US patent 10596158 (Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof) held by Akebia Therapeutics, Inc. expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/4418, A61K31/444, A61K9/14, A61K9/2054